These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 10051460)

  • 21. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
    Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
    Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results.
    Kovács A; Schepke M; Heller J; Schild HH; Flacke S
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):290-6. PubMed ID: 19730936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
    Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
    Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].
    Wu X; Li J; Cao J; Wu X; Ni X
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):342-4. PubMed ID: 11825406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
    Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
    Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.
    Zervos EE; Goode SE; Rosemurgy AS
    J Surg Res; 1998 Jan; 74(1):71-5. PubMed ID: 9536977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic changes in portal system after transjugular intrahepatic portosystemic shunts (TIPS)].
    Li W; Xiao Y; Xu H
    Zhonghua Wai Ke Za Zhi; 1995 Aug; 33(8):476-8. PubMed ID: 8706563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
    Masson S; Mardini HA; Rose JD; Record CO
    QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
    Colombato LA; Spahr L; Martinet JP; Dufresne MP; Lafortune M; Fenyves D; Pomier-Layrargues G
    Gut; 1996 Oct; 39(4):600-4. PubMed ID: 8944572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M; Ginès P; Bandi JC; Gilabert R; Sort P; Jiménez W; Garcia-Pagan JC; Bosch J; Arroyo V; Rodés J
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.